
    
      During the phase I study, patients will receive radiation therapy to pelvis (50.4 Gy in
      28fractions), and followed by HDR intracavitary (30Gy in 5 fractions) brachytherapy.
      Concurrent chemotherapy was administered with weekly cisplatin (40 mg/m^2) and an escalating
      dose of weekly Nab-paclitaxel starting at 10 mg/m^2 up to 70 mg/m^2. Chemotherapy agents were
      administered in escalating doses to cohorts of three patients at each dose level.
    
  